MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03382ntm a2200337 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MY-KuUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20260121173950.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
t||||fs|||| 000 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
260121t20252025my a|||fs|||| 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
THE0010300 (Local) |
| Qualifying information |
Hardback |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMPSA |
| Language of cataloging |
eng |
| Transcribing agency |
UMPSA |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FIST .E55 2025 r Bc. |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lau, En Lin, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Investigating the role of complement c3 and c3a in human type 1 diabetes mellitus patients in Malaysia / |
| Statement of responsibility, etc. |
Lau En Lin |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMPSA, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2025 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
© 2025 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 77 pages : |
| Other physical details |
illustrations ; |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| Source |
rda |
| File type |
text file |
| Encoding format |
PDF |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Faculty of Industrial Sciences and Technology |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Final Year Report (Bachelor of Applied Science in Industrial Biotechnology) -- Universiti Malaysia Pahang Al-Sultan Abdullah - 2025 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Include bibliographical reference |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
The incidence of Type 1 diabetes mellitus (T1DM) has increased globally over the years. Accumulating research suggests that the human complement system may contribute to the pathogenesis of diabetes and induce vascular complications that characterize this condition. Several discoveries from countries such as the UK, China and United States indicated a significant level of complement C3 and C3a in T1DM patients compared to healthy individuals. However, no relevant study has been conducted among T1DM patientsin Malaysia. This study investigates the role of complement C3 and C3a in T1DM patients in Malaysia, with the association of phenotypic characteristics such as age group, ethnicity and gender. A total of 18 (9 T1DM patients and 9 health individuals) were involved in this study and blood serum was obtained for both complement C3 and C3a analysis. The human complement C3 sandwich ELISA kit and human complement C3a sandwich ELISA kit were employed to determine both complement C3 and C3a concentrations in blood serum. The Wilcoxon matched-pairs signed rank test with a Pvalue, 0.1641 for complement C3 and P-value > 0.9999 for complement C3a do not demonstrate any appreciable differences among T1DM patient and healthy control. Based on the findings, the complement C3 and C3a level do not associated with phenotypic characteristics (age, gender and ethnicity) among T1DM patients and healthy controls. As evidence, both Wilcoxon matched-pairs signed rank test (gender) and Kruskal-Wallis tests (age group and ethnicity) were run among T1DM patients and healthy control. P-values obtained (0.3828, 0.1070 and 0.1341) for complement C3 analysis among this group do not show significant differences with these phenotypic characteristics. The results go same with the complement C3a analysis with a P-value of 0.7422 for gender, 0.5283 for age group, and 0.6769 for ethnicity, demonstrating no statistically significant variations based on these phenotypic factors. Therefore, complement C3 and C3a may not be a good indicator in distinguishing between T1DM patient and healthy control in Malaysia. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Faculty of Industrial Sciences and Technology |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Universities and colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Final Year Report |
| General subdivision |
Dissertations |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Final Year Report |